- Home
- Media Center
- Press releases
- Corporate
Corporate
Ethicon’s HARMONIC FOCUS®+ Shears Now Proven To Produce Vessel Seal Strength Equivalent To Advanced Bipolar Devices
Ultrasonic device known for meticulous dissection now produces lower tissue temperature and less thermal damage critical when working near nerves
New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia
Results served as basis for regulatory filing with U.S. Food and Drug Administration and designation as Priority Review
New Study Shows Reduced Hospital Admissions and Costs for Deep Vein Thrombosis Patients Treated with XARELTO®Compared to Traditional Therapy, With No Difference in Subsequent Hospital Visits
Findings Add to Existing Research Showing XARELTO® Cost-Savings Value Across Multiple Indications
Johnson & Johnson Announces Definitive Agreement To Collaborate With Google To Advance Surgical Robotics
Strategic Collaboration Designed to Develop New Technologies that Offer Surgeons and Health Care Systems Greater Accuracy, Cost Efficiency and Better Outcomes for Patients
The Makers Of ZYRTEC® Partner With Gilt City To Address The Beauty And Fashion Challenges Of Allergy Season
Program Features Actress and Allergy Sufferer Debra Messing & Celebrity Makeup Artist Jamie Greenberg To Provide Head-To-Toe Beauty Inspirations For Women
Phase 3 Study with IMBRUVICA® (ibrutinib) Combination Demonstrates Significant Delay in Disease Progression
Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma at a pre-planned interim analysis
Johnson & Johnson Announces Formation of New Health and Wellness Platform Designed to Transform Health Care Delivery and Improve the Patient Experience
New Patient Athlete™ Program Demonstrates Comprehensive Approach to Driving Sustained Behavior Change and Improved Outcomes
Janssen Launches Three New Research Platforms Focused on Redefining Healthcare
New Focus in Disease Prevention, Disease Interception, and the Microbiome to Propel Scientific Innovation
Depuy Synthes Companies Acquires Olive Medical Corporation
Visualization Platform Technology and Expertise to Broaden Arthroscopy Portfolio